ArticleCureus2025
Analysis of Seroma Formation, Flap Necrosis, and Postoperative Pain Following Modified Radical Mastectomy in Patients With Breast Cancer: A Prospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phillyrin promotes flap survival by mitigating pyroptosis through the TLR4/NF-κB/NLRP3 signaling pathway.Apoptosis : an international journal on programmed cell death · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Breast cancer is one of the leading malignancies among Indian women, and it remains a significant contributor to the global cancer burden. Modified radical mastectomy (MRM), which involves removing the entire breast, nipple-areola complex, and axillary lymph nodes, is commonly performed. However, postoperative complications such as seroma formation, pain, and flap necrosis significantly impact patient recovery and quality of life. Objective This study aimed to evaluate the prevalence and presentation of seroma and flap necrosis, analyze the severity and distribution patterns of post-MRM pain, and assess associations between these complications and clinical parameters. Methods This prospective cohort study was conducted at a single tertiary-care center, Department of General Surgery, Ganesh Shankar Vidyarthi Memorial (GSVM) Medical College, Kanpur, India, from December 2022 to November 2024. One hundred consecutive patients with histologically confirmed breast carcinoma who were planned for MRM were included; patients aged <18 years, with bilateral disease, prior axillary surgery, prior chest wall radiation, local recurrence, metastatic disease, or undergoing reconstruction or breast-conserving surgery were excluded. Postoperative pain was measured using the validated Visual Analog Scale (VAS) on postoperative days (PODs) 7, 15, 30, 60, and 90. Seroma (assessed on POD 14) and flap necrosis were recorded by clinical examination using predefined surgical criteria. Data were collected using a standardized questionnaire and analyzed with descriptive statistics; Chi-square tests were used for categorical associations, and p < 0.05 was considered significant. Results Of 100 patients, 20 (20%) developed flap necrosis, and 26 (26%) experienced seroma. Age showed a significant association with pain severity on POD 7 (χ² = 18.487, p < 0.05) and seroma occurrence (χ² = 7.894, p < 0.05). BMI was strongly associated with seroma formation (χ² = 20.252, p < 0.05). Cancer stage correlated significantly with flap necrosis (χ² = 16.715, p < 0.05). Patients with seroma reported higher pain levels on POD 15 (p < 0.05), POD 30 (p < 0.05), and POD 90 (p < 0.05). Conclusion The findings emphasize the importance of patient-specific risk factor evaluation, including age, BMI, and cancer stage, to prevent complications and optimize postoperative care strategies. Early intervention and improved surgical techniques are essential to minimize seroma, flap necrosis, and pain severity after MRM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.